Ivan Horak

Founder & CEO Tikva Allocell

Seminars

Thursday 13th November 2025
Updates in Developing Effective Biomarker Strategies for CAR-T Therapies
9:00 am
  • Showcasing progress in CAR-T for hematologic malignancies
  • Reviewing updates and innovation in CAR-T for solid tumors
  • Exploring updates on prognostic and predictive biomarkers
Ivan Horak